Since the first introduction of the organic-inorganic hybrid perovskite in the field of optoelectronics, extraordinary progress in both photoelectric-conversion-efficiency and stability of perovskite solar cells (PSCs) have been witnessed. However,...

The need to calibrate to correct for sensor-to-sensor fabrication variation and sensor drift has proven a significant hurdle in the widespread use of biosensors. To maintain clinically relevant (±20% for this application) accuracy, for example, commercial continuous glucose monitors require recalibration several times a day, decreasing convenience and increasing the chance of user errors. Here, however, we demonstrate a "dual-frequency" approach for achieving the calibration-free operation of electrochemical biosensors that generate an output by using square-wave voltammetry to monitor binding-induced changes in electron transfer kinetics. Specifically, we use the square-wave frequency dependence of their response to produce a ratiometric signal, the ratio of peak currents collected at responsive and non- (or low) responsive square-wave frequencies, which is largely insensitive to drift and sensor-to-sensor fabrication variations. Using electrochemical aptamer-based (E-AB) biosensors as our test bed, we demonstrate the accurate and precise operation of sensors against multiple drugs, achieving accuracy in the measurement of their targets of within better than 20% across dynamic ranges of up to 2 orders of magnitude without the need to calibrate each individual sensor.

Graphdiyne (GD), a novel carbon allotrope with a 2D structure comprising benzene rings and carbon-carbon triple bonds, is successfully integrated with ZnO nanoparticles by a wet chemistry method. An ultraviolet photodetector based on these graphdiyne:ZnO nanocomposites exhibits significantly enhanced performance in comparison with a conventional ZnO device. GD may have diverse applications in future optoelectronics.